Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Capital Expenditures (2016 - 2025)

Prothena Corp Public (PRTA) has 14 years of Capital Expenditures data on record, last reported at $10000.0 in Q3 2025.

  • For Q3 2025, Capital Expenditures rose 11.11% year-over-year to $10000.0; the TTM value through Dec 2025 reached $138000.0, down 53.69%, while the annual FY2025 figure was $138000.0, 53.69% down from the prior year.
  • Capital Expenditures reached $10000.0 in Q3 2025 per PRTA's latest filing, down from $86000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.5 million in Q4 2023 and bottomed at $9000.0 in Q3 2024.
  • Average Capital Expenditures over 5 years is $238055.6, with a median of $116500.0 recorded in 2022.
  • Peak YoY movement for Capital Expenditures: surged 925.83% in 2023, then tumbled 97.96% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $319000.0 in 2021, then crashed by 52.66% to $151000.0 in 2022, then soared by 925.83% to $1.5 million in 2023, then tumbled by 97.22% to $43000.0 in 2024, then tumbled by 76.74% to $10000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $10000.0 in Q3 2025, $86000.0 in Q2 2025, and $42000.0 in Q1 2025.